Modulation of bacterial quorum sensing with synthetic ligands
Abstract
The present invention provides compounds and methods for modulation of the quorum sensing of bacteria. In an embodiment, the compounds of the present invention are able to act as replacements for naturally occurring bacterial quorum sensing ligands in a ligand-protein binding system; that is, they imitate the effect of natural ligands and produce an agonistic effect. In another embodiment, the compounds of the present invention are able to act in a manner which disturbs or inhibits the naturally occurring ligand-protein binding system in quorum sensing bacteria; that is, they produce an antagonistic effect. The compounds of the present invention comprise N-acylated-homoserine lactones (AHLs) comprised of a wide range of acyl groups.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A compound having the formula FX1:
or a pharmaceutically acceptable salt or ester thereof,
wherein m is 1, 2, 3, or 4;
each R 1 , R 2 , and R 3 is independently selected from the group consisting of —R, —COOR, —COR, —CON(R) 2 , —OCON(R) 2 , —N(R) 2 , —SR, —SO 2 R, —SOR, —OCOOR, —SO 2 N(R) 2 , and —OR; wherein R is selected from the group consisting of a hydrogen, a halogen, an amine group, a substituted or unsubstituted unbranched C 1 -C 12 acyclic aliphatic group, a substituted or unsubstituted branched C 1 -C 12 acyclic aliphatic group, a substituted or unsubstituted C 3 -C 8 cycloalkyl group, a substituted or unsubstituted C 3 -C 8 cycloalkenyl group, a fluorinated C 1 -C 12 alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocycle, a substituted or unsubstituted C 1 -C 12 alkoxy group, a fluorinated C 1 -C 12 alkoxy group, a hydroxyl group, a nitrile group, an azide group, a nitro group, an acyl group, a thiol group, and a protecting group; additionally, R and R can form a ring;
X is selected from the group consisting of S, O, NH, and CH 2 .
Y is selected from the group consisting of:
L is
wherein one or more CH 2 groups may be replaced by NH, O, S, a carbonyl (C═O), or a sulfonyl (S═O or O=S=O); two adjacent CH 2 groups may be replaced by —CH═CH— or —C≡C—; and wherein p is selected from the range of 0 to 15;
Z is selected from the group consisting of:
and and n can be 0 or 1; and
A is selected from the group consisting of an aryl group, a C 5 -C 8 cycloalkyl group, a C 5 -C 8 cycloalkenyl group, a heterocycle having a ring size of 5 to 8 atoms with 1, 2, or 3 heteroatoms in the ring, an unbranched C 1 -C 12 acyclic aliphatic group, or a branched C 1 -C 12 acyclic aliphatic group, all of which may have one or more substituents selected from the group consisting of —R, —COOR, —COR, —CON(R) 2 , —OCON(R) 2 , —N(R) 2 , —SR, —SO 2 R, —SOR, —OCOOR, —SO 2 N(R) 2 , and —OR; wherein R is selected from the group consisting of a hydrogen, a halogen, an amine group, a substituted or unsubstituted unbranched C 1 -C 12 acyclic aliphatic group, a substituted or unsubstituted branched C 1 -C 12 acyclic aliphatic group, a substituted or unsubstituted C 3 -C 8 cycloalkyl group, a substituted or unsubstituted C 3 -C 8 cycloalkenyl group, a fluorinated C 1 -C 12 alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocycle, a substituted or unsubstituted C 1 -C 12 alkoxy group, a fluorinated C 1 -C 12 alkoxy group, a hydroxyl group, a nitrile group, an azide group, a nitro group, an acyl group, a thiol group, and a protecting group; additionally, R and R can form a ring.
2 . The compound, salt or ester of claim 1 , wherein R 1 , R 2 , and R 3 are H and wherein X is O.
3 . The compound, salt or ester of claim 1 , wherein n is 0.
4 . The compound, salt or ester of claim 1 , wherein m is 1.
5 . The compound, salt or ester of claim 1 , wherein A is selected from the group consisting of a substituted aryl group, an unsubstituted aryl group, a substituted C 5 -C 8 cycloalkyl group, and an unsubstituted C 5 -C 8 cycloalkyl group.
6 . The compound, salt or ester of claim 1 , wherein A is selected from the group consisting of:
7 . The compound, salt or ester of claim 1 , wherein A is a halogen or nitrile substituted aryl group
8 . The compound, salt or ester of claim 1 , wherein A is a hydroxyl, thiol, or alkoxy substituted aryl group.
9 . The compound, salt or ester of claim 1 , wherein A is selected from the group consisting of:
10 . The compound, salt or ester of claim 1 , wherein A is a substituted or unsubstituted heterocycle having a ring size of 5 to 8 atoms with 1, 2, or 3 heteroatoms in the ring.
11 . The compound of claim 1 , wherein A is selected from the group consisting of:
12 . The compound of claim 1 , wherein A is selected from the group consisting of a fluorinated unbranched C 1 -C 12 acyclic aliphatic group, and a fluorinated branched C 1 -C 12 acyclic aliphatic group.
13 . The compound of claim 1 of formula:
or a pharmaceutically acceptable salt or ester thereof,
wherein:
Y is selected from the group consisting of:
L is
p is 1, 2 or 3; and
A is selected from the group consisting of:
14 . The compound of claim 1 , wherein A is
15 . A method for treating a bacterial infection comprising the step of administering an effective amount of a compound of claim 1 .
16 . The method of claim 14 , wherein said treatment comprises disrupting or inhibiting biofilm formation.
17 . The method of claim 15 for treating a bacterial infection of a quorum-sensing bacterium in a subject comprising the step of administering an effective amount of a compound of claim 1 to a subject in need of such treatment.
18 . The method of claim 17 , wherein said bacterium is of a genus selected from the group consisting of Aeromonas, Agrobacterium, Burkholderia, Chromobacterium, Enterobacter, Erwinia, Escherichia, Nitrosomas, Obesumbacterium, Pantoea, Pseudomonas, Ralstonia, Rhisobium, Rhodobacter, Serratia, Vibrio, Xenorhabdus , and Yersinia.
19 . The method of claim 17 , wherein said bacterium is of a species selected from the group consisting of Aeromonas hydrophila, Aeromonas salmonicida, Agrobacterium tumefaciens, Burkholderia cepacia, Chromobacterium violaceum, Enterobacter agglomeran, Erwinia carotovora, Erwinia chrysanthemi, Escherichia coli, Nitrosomas europaea, Obesumbacterium proteus, Pantoea stewartii, Pseudomonas aureofaciens, Pseudomonas aeruginosa, Pseudomonas syringae, Ralstonia solanacearum, Rhisobium etli, Rhisobium leguminosarum, Rhodobacter sphaeroides, Serratia liguefaciens, Serratia marcescens, Vibrio anguillarum, Vibrio fischeri, Vibrio cholerae, Xenorhabdus nematophilus, Yersinia enterocolitica, Yersinia pestis, Yersinia pseudotuberculosis, Yersinia medievalis , and Yersinia ruckeri.Join the waitlist — get patent alerts
Track US2022411390A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.